Product Information

DALFAMPRIDINE ER 10 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.3666 per EA under NDC 00591253360. Its NADAC has been published 228 times since Jul 6, 2022.

FDA first approved this application on Jan 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DALFAMPRIDINE ER 10 MG TABLET

Dalfampridine
$0.3666per EA

Strength

10 mg/1

NDC

00591253360

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DALFAMPRIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA206836

FDA Approved

1/23/2017

TE Code

AB

On Market Since

5/31/2022

Pharmacological Classes

Potassium Channel Antagonists
Potassium Channel Blocker

Price Statistics

The NADAC for DALFAMPRIDINE ER 10 MG TABLET has been published 228 times since Jul 6, 2022, and over the history we have for it it has declined 31.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3666 per EA
All-time high$0.7088 (Nov 13, 2024)
All-time low$0.3640 (May 20, 2026)
52-week high$0.4824
52-week low$0.3640
Median price$0.4941
Average price$0.4993
Largest weekly change+42.4% (Oct 23, 2024)
Weeks tracked228
Tracking sinceJul 6, 2022

Price History

1W

0.0%

1M

-8.2%

3M

-11.2%

6M

-1.6%

1Y

-21.6%

3Y

-24.4%

5Y

N/A

All

-31.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DALFAMPRIDINE ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DALFAMPRIDINE ER 10 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.3666 per EA (NDC 00591253360), effective Nov 11, 2026.

How has the price of DALFAMPRIDINE ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has declined 31.0%. It has been tracked across 228 weekly CMS publications since Jul 6, 2022.

What are the highest and lowest recorded NADAC prices for DALFAMPRIDINE ER 10 MG TABLET?

Since Jul 6, 2022, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has ranged from a low of $0.3640 (May 20, 2026) to a high of $0.7088 (Nov 13, 2024), with a median of $0.4941 per EA.

Are there cheaper alternatives to DALFAMPRIDINE ER 10 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DALFAMPRIDINE ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DALFAMPRIDINE ER 10 MG TABLET?

DALFAMPRIDINE ER 10 MG TABLET (NDC 00591253360) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.